Mono Pharmacare Limited
Book Built Issue IPO · NSE
- Price band
- ₹26 - ₹28
- Lot size
- 4,000 shares
- Issue amount
- ₹14.84 cr
- Total subscription
- 13.47×
- Opens
- 28 Aug 2023
- Closes
- 30 Aug 2023
- Allotment
- 4 Sept 2023
- Listing
- 7 Sept 2023
Offer at a glance
Issue overview
- Issue size
- 53,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,04,000
- Fresh issue
- ₹14.84 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,12,000
- Issue type
- Book Built Issue IPO
- Shares before issue
- 1,23,68,564
- Shares after issue
- 1,76,68,564
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 4,000 | ₹1,12,000 |
| HNI | 2 | 8,000 | ₹2,24,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 1.4 | 15.24 |
| RETAIL | 6.34 | 122.89 |
| NIB | 6.33 | 51.37 |
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Values |
|---|---|
| EPS | 1.99 |
| ROE | 9.01 |
| ROCE | 10.34 |
| RONW | 9.01 |
| PRE IPO(PE) | 0 |
| POST IPO(PE) | 40 |
Values and labels as reported in the issue data.
Company information
Company profile
Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.
Promoters
Panilam Lakhatariya
Supal Lakhatariya
Registrar & documents
Lead manager
Unistone Capital Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
1A, Krinkal Apartment Opp. Mahalaxmi Temple, Paldi Ahmedabad -380007
+91 99780 41356
[email protected]Company website ↗Frequently Asked Questions
What is Mono Pharmacare IPO GMP today?
As of today, Mono Pharmacare IPO Grey Market Premium (GMP) is reported at +₹2 per share. Based on the upper price band of ₹28, the estimated listing price is ₹30 (+7.1% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Mono Pharmacare IPO?
The minimum bid lot size for Mono Pharmacare IPO is 4,000 shares. At the cut-off price of ₹28 per share, retail investors need a minimum application amount of ₹1,12,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Mono Pharmacare IPO allotment status be announced?
The allotment status for Mono Pharmacare IPO is scheduled to be finalized on 4 Sept 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Mono Pharmacare IPO allotment status online by PAN?
To check Mono Pharmacare IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Mono Pharmacare Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.